Kuryszko J, Sławuta P, Sapikowski G
Pol J Vet Sci. 2016;19(2):441-6. doi: 10.1515/pjvs-2016-0056.
There are two kinds of adipose tissue in mammals: white adipose tissue - WAT and brown adipose tissue - BAT. The main function of WAT is accumulation of triacylglycerols whereas the function of BAT is heat generation. At present, WAT is also considered to be an endocrine gland that produces bioactive adipokines, which take part in glucose and lipid metabolism. Considering its endocrine function, the adipose tissue is not a homogeneous gland but a group of a few glands which act differently. Studies on the secretory function of WAT began in 1994 after discovery of leptin known as the satiation hormone, which regulates body energy homeostasis and maintainence of body mass. Apart from leptin, the following belong to adipokines: adiponectin, resistin, apelin, visfatin and cytokines: TNF and IL 6. Adiponectin is a polypeptide hormone of antidiabetic, anti-inflammatory and anti-atherogenic activity. It plays a key role in carbohydrate and fat metabolism. Resistin exerts a counter effect compared to adiponectin and its physiological role is to maintain fasting glycaemia. Visfatin stimulates insulin secretion and increases insulin sensitivity and glucose uptake by muscle cells and adipocytes. Apelin probably increases the insulin sensitivity of tissues. TNF evokes insulin resistance by blocking insulin receptors and inhibits insulin secretion. Approximately 30% of circulating IL 6 comes from adipose tissue. It causes insulin resistance by decreasing the expression of insulin receptors, decreases adipogenesis and adiponectin and visfatin secretion, and stimulates hepatic gluconeogenesis. In 2004, Bays introduced the notion of adiposopathy, defined as dysfunction of the adipose tissue, whose main feature is insulin and leptin resistance as well as the production of inflammatory cytokines: TNF and IL 6 and monocyte chemoattractant protein. This means that excess of adipose tissue, especially visceral adipose tissue, leads to the development of a chronic subclinical inflammatory condition, which favours the development of insulin resistance and Type 2 diabetes. Obesity is a systemic illness caused by energy transformation homeostasis disorder which results in an increase in the amount of body fat mass. It effects approximately 40% of dogs and 20% of cats. Illnesses which accompany obesity result, to a great extent, from the secretive role of adipose tissue, which is still little known, which should be included when planning treatment of an obese animal.
白色脂肪组织(WAT)和棕色脂肪组织(BAT)。WAT的主要功能是储存三酰甘油,而BAT的功能是产热。目前,WAT也被认为是一种能产生生物活性脂肪因子的内分泌腺,这些脂肪因子参与葡萄糖和脂质代谢。鉴于其内分泌功能,脂肪组织并非一个均质的腺体,而是一组功能各异的腺体。1994年发现被称为饱腹感激素的瘦素后,对WAT分泌功能的研究开始了,瘦素可调节机体能量平衡和维持体重。除了瘦素,脂肪因子还包括脂联素、抵抗素、Apelin、内脂素以及细胞因子:肿瘤坏死因子(TNF)和白细胞介素6(IL 6)。脂联素是一种具有抗糖尿病、抗炎和抗动脉粥样硬化活性的多肽激素。它在碳水化合物和脂肪代谢中起关键作用。与脂联素相比,抵抗素发挥相反作用,其生理作用是维持空腹血糖水平。内脂素刺激胰岛素分泌,增加胰岛素敏感性,并促进肌肉细胞和脂肪细胞摄取葡萄糖。Apelin可能会增加组织对胰岛素的敏感性。TNF通过阻断胰岛素受体引发胰岛素抵抗,并抑制胰岛素分泌。循环中的IL 6约30%来自脂肪组织。它通过降低胰岛素受体的表达导致胰岛素抵抗,减少脂肪生成、脂联素和内脂素的分泌,并刺激肝脏糖异生。2004年,贝斯提出了脂肪组织病的概念,定义为脂肪组织功能障碍,其主要特征是胰岛素和瘦素抵抗以及炎症细胞因子:TNF、IL 6和单核细胞趋化蛋白的产生。这意味着过多的脂肪组织,尤其是内脏脂肪组织,会导致慢性亚临床炎症状态的发展,这有利于胰岛素抵抗和2型糖尿病的发生。肥胖是一种由能量转化平衡紊乱引起的全身性疾病,导致体内脂肪量增加。它影响约40%的犬类和20%的猫类。伴随肥胖出现的疾病在很大程度上源于脂肪组织鲜为人知的分泌作用,在规划肥胖动物的治疗方案时应考虑到这一点。